What is Semaglutide?

Semaglutide is a drug used to treat type 2 diabetes and obesity. It primarily lowers blood sugar levels and regulates weight by mimicking the effects of a hormone called glucagon-like peptide-1 (GLP-1) in the human body.

1. Semaglutide is a GLP-1 receptor agonist. By mimicking the effects of GLP-1, it stimulates insulin secretion and inhibits glucagon release, effectively lowering blood sugar levels.

2. Semaglutide not only helps control blood sugar but also slows gastric emptying, increasing satiety and aiding weight management. In multiple clinical trials, semaglutide has demonstrated significant blood sugar-lowering and weight-loss effects.

3. Common side effects with semaglutide include nausea, vomiting, diarrhea, and constipation. These side effects are generally more pronounced at the beginning of treatment but tend to subside over time.

4. Semaglutide is indicated for patients with type 2 diabetes who are unsuitable for or unable to control their blood sugar with other oral hypoglycemic medications, as well as for obese patients with a high body mass index and associated health conditions.

5. Semaglutide is usually administered as a subcutaneous injection once a week. The specific dosage and usage should be adjusted by a professional physician based on the patient's specific condition.